Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

Documenti analoghi

• Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.
  di: Gorse, G J, et al.
  Pubblicazione: (1996)
• Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network.
  di: Gorse, G J, et al.
  Pubblicazione: (1992)
• Probing the HIV gp120 Envelope Glycoprotein Conformation by NMR
  di: Celigoy, Jessica, et al.
  Pubblicazione: (2011)
• Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.
  di: Matthews, T J, et al.
  Pubblicazione: (1987)
• Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.
  di: Wyatt, R, et al.
  Pubblicazione: (1997)